NS-065/NCNP-01: An Antisense Oligonucleotide for Potential Treatment of Exon 53 Skipping in Duchenne Muscular Dystrophy …………… Watanabe N, Nagata T, Satou Y, Masuda S, Saito T, Kitagawa H, Komaki H, Takagaki K, Takeda S. Mol Ther Nucleic Acids. 2018 Dec 7;13:442-449. PubMed 00
Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity …………… O’Reilly D, Kartje ZJ, Ageely EA, Malek-Adamian E, Habibian M, Schofield A, Barkau CL, Rohilla KJ, DeRossett LB, Weigle AT, Damha MJ, Gagnon KT. Nucleic Acids Res. 2018 Dec 4. PubMed 00
Predictable and precise template-free CRISPR editing of pathogenic variants …………… Shen MW, Arbab M, Hsu JY, Worstell D, Culbertson SJ, Krabbe O, Cassa CA, Liu DR, Gifford DK, Sherwood RI. Nature. 2018 Nov;563(7733):646-651. PubMed 00
Synthetic Oligonucleotides Inhibit CRISPR-Cpf1-Mediated Genome Editing …………… Li B, Zeng C, Li W, Zhang X, Luo X, Zhao W, Zhang C, Dong Y. Cell Rep. 2018 Dec 18;25(12):3262-3272.e3. PubMed 00